10.37 USD
▼-0.86-7.66%
盘后 12.74 0.00%
2026-09-15
市值
$138.08M
市盈率
—
EPS
-4.00
股息率
—
52 周区间
5.06 – 17.43
成交量
287.81K
Beta
1.41
目标价
43.09
52W 低 5.0652W 高 17.43
价格走势
公司简介
Immunic, Inc., a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. Its lead development program is IMU-838, which is in Phase 3 clinical and phase 2 clinical development for patients with relapsing and progressive multiple sclerosis; and moderate-to-severe ulcerative colitis. The company also develops IMU-856, which is entering Phase 2 clinical trial, for the restoration of the intestinal barrier function in patien...